TRPC6 and diabetes mellitus: In DM subjects, the expression of p22phox, TRPC6 and SOCS3 were found to be increased up to 4.03-fold (p < 0.005), 2.92-fold (p < 0.004) and 6.00-fold (p < 0.004) respectively, when compared to control subjects.